Market Tracker

02/24 5:16pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

46.62
Delayed Data
As of Feb 24
 +0.37 / +0.80%
Today’s Change
31.38
Today|||52-Week Range
80.11
+24.52%
Year-to-Date

Today’s Trading

Previous close46.25
Today’s open45.90
Day’s range45.00 - 47.15
Volume642,690
Average volume (3 months)1,270,859
Market cap$4.0B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-7.90%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book4.35

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co+0.22+0.42%
AGNPRAAllergan plc-4.58-0.53%
CTLTCatalent Inc+0.12+0.43%
GRFSGrifols SA+0.01+0.06%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$1.29
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts